Continuous and intermittent levamisole. A controlled trial.

AUTOR(ES)

Scott, J

RESUMO

A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.

Documentos Relacionados

• Rectal ulcer associated with levamisole.
• Intermediate coronary care. A controlled trial.
• Joint irrigation in rheumatoid arthritis: a controlled trial.
• Penotrane in blepharitis. A double-blind controlled trial.
• Neutropenia during treatment of rheumatoid arthritis with levamisole.